issues
search
opensafely
/
antibody-and-antiviral-deployment
While vaccines remain the best strategy to prevent COVID-19, mAbs could potentially benefit certain vulnerable populations before or after exposure to SARS-CoV-2, such as the unvaccinated or recently vaccinated high-risk patients.
MIT License
1
stars
4
forks
source link
Update RMarkdown for report with updated data
#62
Closed
rose-higgins
closed
6 months ago